跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-ALPRAZ TABLET 0.25 mg - HSA Drug Approval Details
Approvals
/
HSA
/
APO-ALPRAZ TABLET 0.25 mg
Approved
THERAPEUTIC
APO-ALPRAZ TABLET 0.25 mg
APOTEX INCApotex Inc.
🇸🇬 Health Sciences Authority
Approval Date
Oct 6, 1994
Approval ID
039aec471b5e5ea9
Company
APOTEX INCApotex Inc.
Type
Therapeutic
Approval Details
Approval Id
039aec471b5e5ea9
Drug Name
APO-ALPRAZ TABLET 0.25 mg
Product Name
APO-ALPRAZ TABLET 0.25 mg
Approval Number
SIN07872P
Approval Date
1994-10-06
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
N05BA12
Atc Item Name
alprazolam
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
ALPRAZOLAM
0.25 mg
ALPRAZOLAM
0.25 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 6, 1994
Approval ID
039aec471b5e5ea9
Type
Therapeutic
Back to HSA Approvals